These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7909438)

  • 21. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
    Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS
    Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome-C-erbB2 antisense oligodoxynucleotides in human ovarian cancer cells.
    Shen M; Feng Y; Ge B; Wu Z; Zhu M
    Chin Med J (Engl); 2001 Jul; 114(7):735-7. PubMed ID: 11780339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB; Hota C; Wilson SM; Chambers AF
    Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
    Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER2/neu antisense targeting of human breast carcinoma.
    Roh H; Pippin JA; Green DW; Boswell CB; Hirose CT; Mokadam N; Drebin JA
    Oncogene; 2000 Dec; 19(53):6138-43. PubMed ID: 11156527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines.
    Grooteclaes M; Pasleau F; Dijkmans H; Berzi P; Albert A; Winkler-Gol R
    Cancer Res; 1994 Aug; 54(15):4193-9. PubMed ID: 7913414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid induction of Jak2 and Sp1 in T cells by phosphorothioate oligonucleotides.
    Too CK
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):87-94. PubMed ID: 9593046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-erbB2 amplification and overexpression in human tumors.
    Lofts FJ; Gullick WJ
    Cancer Treat Res; 1992; 61():161-79. PubMed ID: 1360230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
    Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines.
    Riedel F; Götte K; Goessler U; Sadick H; Hörmann K
    Anticancer Res; 2004; 24(4):2179-83. PubMed ID: 15330158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.
    Soldatenkov VA; Dritschilo A; Wang FH; Olah Z; Anderson WB; Kasid U
    Cancer J Sci Am; 1997; 3(1):13-20. PubMed ID: 9072302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
    Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
    J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J
    Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of hepatocyte growth factor and c-Met mRNAs in isografts in experimental rat liver transplants.
    Ogasawara H; Tanabe M; Furuya T; Murase N; Iwatsuki S; Nakamura T; Katyal SL; Shinozuka H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):149-51. PubMed ID: 7679809
    [No Abstract]   [Full Text] [Related]  

  • 40. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.
    Skutella T; Stöhr T; Probst JC; Ramalho-Ortigao FJ; Holsboer F; Jirikowski GF
    Horm Metab Res; 1994 Oct; 26(10):460-4. PubMed ID: 7851868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.